Teneligliptin Hydrobromide Hydrate

Teneligliptin Hydrobromide Hydrate(MP-513 hydrobromide hydrate) is a potent, competitive, and long-lasting inhibitor of DPP-4. It competitively inhibited rhDPP-4, human plasma, and rat plasma with IC50 values of 0.889, 1.75, and 1.35 nM respectively. It suppresses high glucose-mediated mitochondrial dysfunction and can be used for treatment of type 2 diabetes.

Trivial name MP-513 hydrobromide hydrate
Catalog Number E4814
Molecular Formula C25H21N5O.2HCl
CAS# 1572583-29-9
Inchi InChI=1S/C25H21N5O.2ClH/c26-25(12-4-13-25)18-9-7-17(8-10-18)22-19(16-5-2-1-3-6-16)15-20-21(27-22)11-14-30-23(20)28-29-24(30)31;;/h1-3,5-11,14-15H,4,12-13,26H2,(H,29,31);2*1H
Inchi Key HWUHTJIKQZZBRA-UHFFFAOYSA-N
SMILES C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N.Cl.Cl
Size 25mg
Supplier Page http://www.selleckchem.com/products/teneligliptin-hydrobromide-hydrate.html
Additional Information https://file.selleck.cn/downloads/struct/E4814-Teneligliptin-Hydrobromide-Hydrate-chemical-structure.png